Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition

Volumn 83, Issue 6, 2006, Pages 1337-1344

  Szajewska, Hania ^a   Horvath, Andrea ^a   Koletzko, Berthold ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Development; Feeding; Long chain polyunsaturated fatty acids; Nutrition; Pregnancy; Supplementation

Indexed keywords

OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ARTICLE; BLEEDING; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DIET SUPPLEMENTATION; ECLAMPSIA; EMBASE; GASTROINTESTINAL SYMPTOM; HUMAN; INFORMATION RETRIEVAL; LOW BIRTH WEIGHT; MEDLINE; META ANALYSIS; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; RISK FACTOR; SYSTEMATIC REVIEW; TASTE DISORDER; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; FETUS DEVELOPMENT; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS;

EID: 33745597677     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.6.1337     Document Type: Article

References (47)

1. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:121-9.
2. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-38.
3. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992;27:901-7.
4. Zurier RB. Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 1993;48:57-62.
5. Berghaus T, Demmelmair H, Koletzko B. Essential fatty acids and their long-chain polyunsaturated metabolites in maternal and cord plasma triglycerides during late gestation. Biol Neonate 2000;77:96-100.
6. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991;30:39-103.
7. Arbuckle LD, Innis SM. Docosahexaenoic acid is transferred through maternal diet to milk and to tissues of natural milk-fed piglets. J Nutr 1993;123:1668-75.
8. Koletzko B. Lipid supply and metabolism in infancy. Curr Opin Clin Nutr Metab Care 1998;1:171-7.
9. Yavin E, Green P. Distribution, processing and selective esterification of essential fatty acid metabolites in the fetal brain. In: Galli C, Simopoulos AP, Tremoli E, eds. World review of nutrition and diet. Basel, Switzerland: Karger, 1994:134-8.
10. 13C-labeled fatty acids in humans. J Lipid Res 2003;44:49-55.
11. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 1995;74:55-68.
12. Otto SJ, Houwelingen AC, Antal M, et al. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr 1997;51:232-42.
13. Decsi T, Koletzko B. n-3 Fatty acids and pregnancy outcomes. Curr Opin Clin Nutr Metab Care 2005;8:161-6.
14. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108:E82.
15. Olsen SF, Hansen HS, Sorensen TI, et al. Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986;2:367-9.
16. Olsen SF. Is supplementation with marine omega-3 fatty acids during pregnancy a useful tool in the prevention of preterm birth? Clin Obstet Gynecol 2004;47:768-74.
17. Koletzko B, Agostoni C, Carlson SE, et al. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr 2001;90:460-4.
18. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retreival of reports of controlled trials using PubMed. Int J Epidemiol 2002;31:150-3.
19. Smuts CM, Borod E, Peeples JM, Carlson SE. High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 2003;38:407-14.
20. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.
21. Olsen SF, Sorensen JD, Secher NJ, et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992;339:1003-7.
22. Hogg RV, Craig AT. Introduction to mathematical statistics. 5th ed. Englewood Cliffs, NJ: Prentice Hall, Inc, 1995.
23. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-34.
24. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003;88:F383-90.
25. Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 2004;32:132-6.
26. Colombo J, Kannass KN, Shaddy DJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-67.
27. Boris J, Jensen B, Salvig JD, Secher NJ, Olsen SF. A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids 2004;39:1191-6.
28. Borod E, Atkinson R, Barclay WR, Carlson SE. Effects of third trimester consumption of eggs high in docosahexaenoic acid on docosahexaenoic acid status and pregnancy. Lipids 1999;34(suppl):S231.
29. de Groot RH, Hornstra G, van Houwelingen AC, Roumen F. Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am J Clin Nutr 2004;79:251-60.
30. de Groot RH, Adam J, Jolles J, Hornstra. Alpha-linolenic acid supplementation during human pregnancy does not effect cognitive functioning. Prostaglandins Leukot Essent Fatty Acids 2004;70:41-7.
31. Haugen G, Helland I. Influence of preeclampsia or maternal intake of omega-3 fatty acids on the vasoactive effect of prostaglandin F-two-alpha in human umbilical arteries. Gynecol Obstet Invest 2001;52:75-81.
32. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003;111:e39-44.
33. van Houwelingen AC, Sorensen JD, Hornstra G, et al. Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br J Nutr 1995;74:723-31.
34. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003;90:135-45.
35. Olsen SF, Soorensen JD, Sechere NJ, et al. Fish oil supplementation and duration of pregnancy. A randomised controlled trial. Ugeskr Laeger 1994;156:1302-7.
36. Otto SJ, van Houwelingen AC, Hornstra G. The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot Essent Fatty Acids 2000;63:323-8.
37. Salvig JD, Olsen SF, Secher NJ. Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. Br J Obstet Gynaecol 1996;103:529-33.
38. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;168:915-22.
39. Sorensen JD, Olsen SF, Secher NJ, Jespersen J. Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis. A randomized controlled study. Fibrinolysis 1994;8:54-60.
40. Koletzko B. Early nutrition and its later consequences: new opportunities. Adv Exp Med Biol 2005;569:1-12.
41. Barker D. Fetal origins of coronary heart disease. Br Med J 1995;171-4.
42. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions 4.2.4. In: The Cochrane Library. Chichester, United Kingdom: Wiley & Sons, Ltd., 2005.
43. Olsen SF, Olsen J, Frische G. Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epidemiol 1990;19:971-7.
44. Olsen SF, Grandjean P, Weihe P, Videro T. Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health 1993;47:436-40.
45. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol 2004;160:774-83.
46. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. Br J Obstet Gynaecol 2000;107:382-95.
47. Malcolm CA, Hamilton R, McCulloch DL, et al. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003;44:3685-91.